Novacyt flags possible £3m hit from Covid test regulations change
2nd Nov 2021 11:45
(Sharecast News) - Clinical diagnostics specialist Novacyt updated the market on the availability of its Covid-19 tests in the UK on Tuesday, following the implementation of amendments to the UK Health Security Agency's coronavirus test device regulations, or 'CTDA'.
Read moreNovacyt launches new 'Winterplex' test, lateral flow tests delayed
30th Sep 2021 09:37
(Sharecast News) - Clinical diagnostics specialist Novacyt issued a research and development update on Thursday, including the launch of a new CE-marked 'Winterplex' polymerase chain reaction (PCR) test to diagnose Covid-19, respiratory syncytial virus (RSV) and types of influenza.
Read moreNovacyt swings to first-half loss amid DHSC dispute
27th Sep 2021 08:15
(Sharecast News) - Clinical diagnostics specialist Novacyt reported group consolidated unaudited revenue of £54m in its first half on Monday, down from £63.3m year-on-year, which excluded £40.8m of Department of Health and Social Care (DHSC) revenues, while that contract dispute continued.
Read moreNovacyt FY revenues potentially 'materially affected' by outcome of DHSC dispute
16th Sep 2021 11:05
(Sharecast News) - Biotechnology company Novacyt warned on first-half revenues on Thursday as a result of its ongoing dispute with the US Department of Health and Social Care.
Read moreFirst half revenues up more than 50pc for Novacyt
18th Aug 2021 10:12
(Sharecast News) - Novacyt said in an update on Wednesday that unaudited revenue in its first half was ahead more than 50% year-on-year, at £94.7m.
Read moreNovacyt appoints David Allmond as new chief executive
29th Jul 2021 15:31
(Sharecast News) - Clinical diagnostics specialist Novacyt announced the appointment of David Allmond as its new chief executive officer and a member of its board on Thursday, effective from 18 October.
Read moreNovacyt launches two new rapid Covid-19 test products
29th Jun 2021 09:03
(Sharecast News) - Clinical diagnostics specialist Novacyt announced the planned launch of two 'PathFlow' Covid-19 antigen lateral flow tests on Tuesday, to strengthen its Covid-19 portfolio and to pursue significant new market opportunities, particularly in point-of-care settings.
Read moreNovacyt swings to huge profit after pivot to Covid test portfolio
22nd Jun 2021 08:46
(Sharecast News) - Clinical diagnostics specialist Novacyt announced a more-than-twentyfold improvement in group consolidated revenue in its full-year results on Tuesday, to £277.2m, as its gross margin improved to 76.3% in 2020, from 64% in 2019.
Read moreNovacyt test for variants of concern included in NHS framework
17th May 2021 09:16
(Sharecast News) - Clinical diagnostics company Novacyt announced on Monday that its 'SNPsig' SARS-CoV-2 polymerase chain reaction (PCR) genotyping portfolio has been included in the NHS England framework for detecting Covid-19 'variants of concern'.
Read moreNovacyt makes progress with Covid-19 programmes
23rd Apr 2021 16:28
(Sharecast News) - Clinical diagnostics specialist Novacyt updated the market on the progress of its near-term Covid-19 research and development programmes on Friday, addressing "rapidly-evolving" testing demands, particularly as SARS-CoV-2 continued to mutate globally.
Read moreNovacyt dispute with DHSC to dent 2021 profit, shares slide
9th Apr 2021 15:23
(Sharecast News) - Novacyt said on Friday that a dispute with the Department of Health and Social Care (DHSC) over a supply contract could have a "material" impact on fourth-quarter revenues and dent 2021 profit and revenue, sending its shares sharply lower.
Read moreNovacyt launches CE-marked rapid Covid-19 variant test
24th Mar 2021 10:02
(Sharecast News) - Clinical diagnostics specialist Novacyt announced the launch of 'SNPsig VariPLEX' on Wednesday, as a CE-marked polymerase chain reaction (PCR) assay panel, able to detect the four currently-recognised Covid-19 variants of concern, and the two most biologically significant mutations, in a single kit.
Read moreNovacyt launches mobile Covid-19 testing labs
17th Mar 2021 08:32
(Sharecast News) - Clinical diagnostics specialist Novacyt announced the expansion of its 'VersaLab' service on Wednesday, with the launch of mobile processing laboratories to provide rapid turnaround polymerase chain reaction (PCR) testing on-site.
Read moreCovid-19 testing focus underpinning progress at Novacyt
24th Feb 2021 11:35
(Sharecast News) - Clinical diagnostics company Novacyt updated the market on the progress of its near-term research and development programmes on Wednesday, including the expansion of its product portfolio, clinical trial activity and the publication of independent validations of its Covid-19 tests.
Read moreNovacyt launches new Covid-19 test assays for variant strains
2nd Feb 2021 09:08
(Sharecast News) - Clinical diagnostics company Novacyt announced the launch of a new portfolio of assays under the brand name 'SNPsig' on Tuesday, to aid the diagnosis of the new variants of SARS-CoV-2, the virus which causes the Covid-19 disease.
Read more